The Ministry of Health has released this Wednesday its third report on "Financing of innovative medicines in Spain," which confirms an accumulated reduction of 70 days in the total time elapsed from the European authorization of a drug until it obtains public funding in Spain.The document analyzes the evolution of...
The European Federation of Pharmaceutical Industries, of which Farmaindustria is a part, released an analysis this Tuesday concluding that, between 2014 and 2024, investment in Europe of 11.67 billion euros in new innovative medicines has generated a return of close to six times that figure in the form of social,...
Question: Let's start by talking about the amendments that insist on protecting incentives for innovation and economic viability of orphan drugs. Do you think the current European framework sufficiently guarantees that balance or that it needs to be strengthened?Answer: Responding very directly, I believe it is necessary to reinforce it,...
Last March, the European Parliament's SANT Committee approved both the directive and the regulation of the pharmaceutical legislative package, agreed on December 11 in the meetings between the European Commission, the Council, and the European Parliament, the well-known trilogues.The result of the vote was 29 votes in favor, three against,...